Insider Transactions in Q4 2024 at Ardelyx, Inc. (ARDX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2024
|
David M Mott Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+5.44%
|
$0
$0.55 P/Share
|
|
Dec 19
2024
|
David M Mott Director |
BUY
Open market or private purchase
|
Direct |
213,300
+11.52%
|
$853,200
$4.67 P/Share
|
|
Dec 10
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.13%
|
$125,000
$5.26 P/Share
|
|
Dec 10
2024
|
Michael Raab President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+2.08%
|
$0
$0.99 P/Share
|
|
Nov 25
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.13%
|
$125,000
$5.38 P/Share
|
|
Nov 20
2024
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
2,243
-1.46%
|
$8,972
$4.79 P/Share
|
|
Nov 20
2024
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,941
-1.64%
|
$19,764
$4.79 P/Share
|
|
Nov 20
2024
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,366
-2.33%
|
$29,464
$4.79 P/Share
|
|
Nov 20
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
31,980
-2.65%
|
$127,920
$4.79 P/Share
|
|
Nov 20
2024
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,260
-1.77%
|
$21,040
$4.79 P/Share
|
|
Nov 20
2024
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
4,941
-1.55%
|
$19,764
$4.79 P/Share
|
|
Nov 20
2024
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
7,046
-3.66%
|
$28,184
$4.79 P/Share
|
|
Nov 13
2024
|
David M Mott Director |
BUY
Open market or private purchase
|
Direct |
215,868
+13.15%
|
$863,472
$4.62 P/Share
|
|
Nov 11
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
2,743
-0.23%
|
$10,972
$4.9 P/Share
|
|
Nov 06
2024
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
27,171
-15.03%
|
$163,026
$6.1 P/Share
|
|
Nov 06
2024
|
David P. Rosenbaum Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
27,171
+13.07%
|
$54,342
$2.32 P/Share
|
|
Nov 04
2024
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
27,172
-15.03%
|
$135,860
$5.95 P/Share
|
|
Nov 04
2024
|
David P. Rosenbaum Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
27,172
+13.07%
|
$54,344
$2.32 P/Share
|
|
Oct 28
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.02%
|
$125,000
$5.91 P/Share
|
|
Oct 28
2024
|
Michael Raab President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+1.98%
|
$0
$0.99 P/Share
|
|
Oct 11
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.62%
|
$45,000
$6.01 P/Share
|